Badania Kliniczne z udziałem kobiet w ciąży
11 March
Webinar "Clinical trials on pregnant woman" - WE! are the Clinical Research

Kozminski University focuses on education based on reliable scientific knowledge, passed on in a modern way, by a properly prepared, experienced team of scientists, business practitioners and entrepreneurs. KU sees his development in the internationalization of the educational process, and international cooperation is one of the elements of the university's success.

The „WE! are Clinical Research" Movement was created with the intention of introducing international contribution to the discussion about clinical trials. In its assumptions, it wants to connect representatives of various environments, industries and nationalities in order to exchange experiences and build wider cooperation and understanding of the goals of our activities.

Therefore, on behalf of the Kozminski University and ours, we invite you to the second Webinar of the Movement „WE! are Clinical Research” Movement.

Clinical trials on pregnant woman

In the vast majority of clinical trials, pregnancy is one of the main exclusion criteria. The requirement to use additional contraception when participating in a clinical trial is equally common in order not to father a child during the course of a clinical trial. However, pregnant women also get sick, they also struggle with numerous health problems - regardless of or as a result of pregnancy.

The participation of pregnant women in clinical trials should not be associated only with a prohibition. These women should not be restricted in their access to the best treatments.

The aim of this webinar is to show that research on pregnant women is needed and, moreover, is being conducted successfully in many centers. Unfortunately, awareness of this issue is still relatively low, both common and in the clinical trials community.

The event is under the honorary patronage of the Medical Research Agency

ABM logo

“Pregnant women are under-represented in clinical trials in Europe. Safe and effective treatment during pregnancy is essential, and the lack of an established dosing regimen during this period could endanger the health of both mother and child.   Without conducting clinical trials on a large, representative group of pregnant women, it is impossible to allow the use of certain substances in this group. In some situations, it deprives you of the possibility of using modern therapies, unavailable outside the clinical trial.” after. President of the Medical Research Agency, Radosław Sierpiński, PhD

Organizational matters

Time and place: March 11th, 2021 at 6:00 PM CET, online.

The webinar will be conducted in Polish and English. Simultaneous translation will be available thanks to the support of the British Embassy in Poland. Technical issues will be communicated to those registered with a link to the event.

We act and support!

Every activity of the "WE! are the Clinical Research" will be associated with the support of the Kozminski Foundation, whose goals include activities for the development of science, education and upbringing and supporting gifted youth.

The cost of participation in the Webinar is PLN 50 and the entire amount collected is allocated to the activities of the Kozminski Foundation.

See you at the webinar!

partnerzy badania kliniczne
Registration form
Registration form
Badania Kliniczne z udziałem kobiet w ciąży
prof. Anna David

Professor Anna David is consultant in obstetrics and maternal/fetal medicine at UCLH. Joining University College London (UCL) in 2000 from Queen Charlotte’s Hospital, Professor David was awarded a PhD for her work on fetal gene therapy for treatment of early onset genetic disease in 2005. She then trained in maternal fetal medicine at UCLH under professor Charles Rodeck. In 2008 she was awarded a prestigious UK HEFCE/Department of Health funded senior clinical lectureship in women’s health at UCL and UCLH when she took up a consultant post. 
Anna offers a range of diagnostic and therapeutic services in the fetal medicine unit at UCLH. She specialises in cases where the baby has a structural anomaly, a genetic condition or when the baby’s growth is poor (fetal growth restriction). She has close links with the talented UCLH neonatal team that are expert in caring for the smallest preterm infants. 
Professor David set up the preterm birth clinical service at UCLH in 2008, which is now one of the busiest in the UK, providing continuity of care in a nurturing environment. The comprehensive service offers pre-conceptual counselling, a wide range of cerclage and other treatments and predictive tests. She is research lead at the Centre for Prenatal Therapy, the team who performed the first fetal surgery for spina bifida in the UK in 2018. 
Professor David is director of the EGA Institute for Women's Health, UCL. Her team are developing new treatments for fetal growth restriction using maternal gene therapy, and is pioneering the first clinical trial of in utero stem cell transplantation for brittle bone disease. She has won awards for her mentorship of academic trainees and colleagues, and is a fellow of the Royal College of Obstetricians and Gynaecologists.

dr hab. n. o zdr. Aleksandra Wesołowska

Researcher at the Medical University of Warsaw, Department of Medical Biology, Faculty of Health Sciences, head of the University Laboratory of Research on Feminine Milk and Lactation at the Regional Milk Bank at the Specialist Hospital. St. Families in Warsaw.
Associate of the Medical Research Agency, Secretary of the Scientific Working Group at the President of ABM. A graduate of Kozminski University in the field of Conducting and Organization of clinical trials. President and co-founder of the Foundation of the Bank of Women's Milk, established in 2010, acting as an expert and patient organization popularizing knowledge about human milk banks and the way such institutions operate in Poland and abroad.
Winner of the prestigious award of the Minister of Science and Higher Education (2019) for outstanding scientific and scientific and technical achievements in the category of research for the benefit of society (2018).
During the COVID-19 pandemic, together with a nationwide team, she undertook research on the risk of infection of a child from a mother suffering from COVID-19 and the safety of the COVID-19 vaccine in the perinatal period.

Coordination of the meeting
Wanda Widziszewska; Beata Falęcka